CNTMF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 1 closing price
Capitalization
21.83M
33 days until earnings call
CRLBF
Price
$0.70
Change
-$0.03 (-4.11%)
Updated
Apr 1 closing price
Capitalization
501.04M
42 days until earnings call
Ad is loading...

CNTMF vs CRLBF

Header iconCNTMF vs CRLBF Comparison
Open Charts CNTMF vs CRLBFBanner chart's image
FLUENT
Price$0.06
Change-$0.00 (-0.00%)
Volume$30.08K
Capitalization21.83M
Cresco Labs
Price$0.70
Change-$0.03 (-4.11%)
Volume$255.43K
Capitalization501.04M
CNTMF vs CRLBF Comparison Chart
Loading...
CNTMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTMF vs. CRLBF commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTMF is a Hold and CRLBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CNTMF: $0.06 vs. CRLBF: $0.70)
Brand notoriety: CNTMF and CRLBF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CNTMF: 15% vs. CRLBF: 38%
Market capitalization -- CNTMF: $21.83M vs. CRLBF: $501.04M
CNTMF [@Pharmaceuticals: Other] is valued at $21.83M. CRLBF’s [@Pharmaceuticals: Other] market capitalization is $501.04M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTMF’s FA Score shows that 0 FA rating(s) are green whileCRLBF’s FA Score has 0 green FA rating(s).

  • CNTMF’s FA Score: 0 green, 5 red.
  • CRLBF’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTMF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTMF’s TA Score shows that 3 TA indicator(s) are bullish while CRLBF’s TA Score has 3 bullish TA indicator(s).

  • CNTMF’s TA Score: 3 bullish, 5 bearish.
  • CRLBF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CNTMF and CRLBF are a bad buy in the short-term.

Price Growth

CNTMF (@Pharmaceuticals: Other) experienced а +0.83% price change this week, while CRLBF (@Pharmaceuticals: Other) price change was -5.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.45%. For the same industry, the average monthly price growth was -0.08%, and the average quarterly price growth was -9.41%.

Reported Earning Dates

CNTMF is expected to report earnings on May 05, 2025.

CRLBF is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($501M) has a higher market cap than CNTMF($21.8M). CNTMF YTD gains are higher at: -16.838 vs. CRLBF (-23.136). CNTMF has higher annual earnings (EBITDA): 6.79M vs. CRLBF (-16.73M). CRLBF has more cash in the bank: 88.8M vs. CNTMF (9.47M). CNTMF has less debt than CRLBF: CNTMF (94.5M) vs CRLBF (678M). CRLBF has higher revenues than CNTMF: CRLBF (822M) vs CNTMF (90M).
CNTMFCRLBFCNTMF / CRLBF
Capitalization21.8M501M4%
EBITDA6.79M-16.73M-41%
Gain YTD-16.838-23.13673%
P/E RatioN/AN/A-
Revenue90M822M11%
Total Cash9.47M88.8M11%
Total Debt94.5M678M14%
FUNDAMENTALS RATINGS
CNTMF vs CRLBF: Fundamental Ratings
CNTMF
CRLBF
OUTLOOK RATING
1..100
1416
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
8991
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNTMF's Valuation (62) in the null industry is in the same range as CRLBF (74). This means that CNTMF’s stock grew similarly to CRLBF’s over the last 12 months.

CNTMF's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that CNTMF’s stock grew similarly to CRLBF’s over the last 12 months.

CRLBF's SMR Rating (94) in the null industry is in the same range as CNTMF (99). This means that CRLBF’s stock grew similarly to CNTMF’s over the last 12 months.

CNTMF's Price Growth Rating (89) in the null industry is in the same range as CRLBF (91). This means that CNTMF’s stock grew similarly to CRLBF’s over the last 12 months.

CNTMF's P/E Growth Rating (97) in the null industry is in the same range as CRLBF (100). This means that CNTMF’s stock grew similarly to CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNTMFCRLBF
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
CNTMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKE10.09N/A
N/A
Skeena Resources Limited
GNRC126.33-0.32
-0.25%
Generac Holdings
ABBV206.27-3.25
-1.55%
ABBVIE
PLAB20.38-0.38
-1.83%
Photronics
IMAB0.79-0.04
-4.38%
I-MAB

CNTMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTMF has been loosely correlated with TCNNF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTMF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTMF
1D Price
Change %
CNTMF100%
+5.22%
TCNNF - CNTMF
49%
Loosely correlated
-1.86%
VRNOF - CNTMF
41%
Loosely correlated
-1.51%
GTBIF - CNTMF
39%
Loosely correlated
-1.20%
CURLF - CNTMF
38%
Loosely correlated
-0.24%
CRLBF - CNTMF
36%
Loosely correlated
-3.13%
More